Literature DB >> 15703684

Commensal bacteria in the gut: learning who our friends are.

Fang Yan1, D Brent Polk.   

Abstract

PURPOSE OF REVIEW: Recent evidence has shown that commensal bacteria regulate intestinal physiology, development, and function. This review focuses on new insights into the effects of these organisms on health and disease. RECENT
FINDINGS: Gastrointestinal tract development and function is determined by communication between the intestinal epithelium and commensal bacteria. Important regulatory interactions between these cells are being defined with early evidence indicating both beneficial and harmful consequences to the host. A subgroup of these bacteria overlaps with probiotic organisms that have preventative and therapeutic potential for diarrhea, inflammatory bowel disease (IBD), atopy, and other diseases, whereas evidence indicates some "nonpathogenic" commensal bacteria may promote an environment conducive to IBD, cancer, and other diseases.
SUMMARY: Progress in understanding the relation between commensal bacteria and human health is likely to promote the identification of new approaches to disease prevention and treatment.

Entities:  

Year:  2004        PMID: 15703684     DOI: 10.1097/00001574-200411000-00011

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  35 in total

Review 1.  Disruption of NF-kappaB signalling by ancient microbial molecules: novel therapies of the future?

Authors:  Fang Yan; D Brent Polk
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

Review 2.  Ten years of bacterial genome sequencing: comparative-genomics-based discoveries.

Authors:  Tim T Binnewies; Yair Motro; Peter F Hallin; Ole Lund; David Dunn; Tom La; David J Hampson; Matthew Bellgard; Trudy M Wassenaar; David W Ussery
Journal:  Funct Integr Genomics       Date:  2006-05-12       Impact factor: 3.410

Review 3.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

4.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

5.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; Robert Whitehead; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

Review 6.  [Outside-in. Probiotic topical agents].

Authors:  T Volz; T Biedermann
Journal:  Hautarzt       Date:  2009-10       Impact factor: 0.751

7.  Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor.

Authors:  Sarika Amdekar; Vinod Singh; Rambir Singh; Poonam Sharma; Poonam Keshav; Avnish Kumar
Journal:  J Clin Immunol       Date:  2010-09-14       Impact factor: 8.317

Review 8.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

9.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

Review 10.  A roadmap for understanding and preventing necrotizing enterocolitis.

Authors:  Josef Neu; Maka Mshvildadze; Volker Mai
Journal:  Curr Gastroenterol Rep       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.